Eruptions in Patients with chronic hepatitis C receiving combination therapy with Telaprevir, Peginterferon and Ribavirin

被引：0
|
作者：
Eleftheriadis, V [1 ]
Stadler, R. [1 ]
机构：
[1] Johannes Wesling Klinikum Minden, Hautklin, Minden, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2012年 / 10卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：869 / 869
页数：1
相关论文
共 50 条
  • [21] Suitable treatment period in patients with virological response during combination therapy of peginterferon and ribavirin for chronic hepatitis C
    Arase, Yasuji
    Suzuki, Fumitaka
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Akuta, Norio
    Hosaka, Tetsuya
    Yatsuji, Hiromi
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    INTERNAL MEDICINE, 2008, 47 (14) : 1301 - 1307
  • [22] The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis C
    Schwarz, Kathleen B.
    Gonzalez-Peralta, Regino P.
    Murray, Karen F.
    Molleston, Jean P.
    Haber, Barbara A.
    Jonas, Maureen M.
    Rosenthal, Philip
    Mohan, Parvathi
    Balistreri, William F.
    Narkewicz, Michael R.
    Smith, Lesley
    Lobritto, Steven J.
    Rossi, Stephen
    Valsamakis, Alexandra
    Goodman, Zachary
    Robuck, Patricia R.
    Barton, Bruce A.
    GASTROENTEROLOGY, 2011, 140 (02) : 450 - U148
  • [23] Peginterferon alpha-2a and ribavirin combination therapy for chronic hepatitis C in patients with hemophilia - preliminary report
    Kim, H.
    Yoo, K.
    Lee, K.
    Lee, Y.
    HAEMOPHILIA, 2008, 14 : 41 - 41
  • [24] Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients
    Dai, Chia-Yen
    Huang, Jee-Fu
    Hsieh, Ming-Yen
    Hou, Nai-Jen
    Lin, Zu-Yau
    Chen, Shinn-Chern
    Hsieh, Ming-Yuh
    Wang, Liang-Yen
    Chang, Wen-Yu
    Chuang, Wan-Long
    Yu, Ming-Lung
    JOURNAL OF HEPATOLOGY, 2009, 50 (04) : 712 - 718
  • [25] Peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus
    Suzuki, Fumitaka
    Akuta, Norio
    Sezaki, Hitomi
    Yatsuji, Hiromi
    Arase, Yasuji
    Suzuki, Yoshiyuki
    Kawamura, Yusuke
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Saitou, Satoshi
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A115 - A115
  • [26] A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C
    Flisiak, Robert
    Shiffman, Mitchell
    Arenas, Juan
    Cheinquer, Hugo
    Nikitin, Igor
    Dong, Yuping
    Rena, Khurram
    Srinivasan, Subasree
    PLOS ONE, 2016, 11 (10):
  • [27] Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C
    Shinya Maekawa
    Nobuyuki Enomoto
    Journal of Gastroenterology, 2009, 44 : 1009 - 1015
  • [28] Hepatic iron influences responses to combination therapy with peginterferon alfa and ribavirin in chronic hepatitis C
    Lin, Tsung-Jung
    Liao, Li-Ying
    Lin, Chih-Lin
    Chang, Ting-An
    Liu, Shu-O
    HEPATO-GASTROENTEROLOGY, 2008, 55 (85) : 1412 - 1415
  • [29] Peginterferon α-2a, Ribavirin and Fluvastatin Combination Therapy for Chronic Hepatitis C in Children and Adolescents
    Etani, Yuri
    Ida, Shinobu
    GASTROENTEROLOGY, 2011, 140 (05) : S456 - S457
  • [30] DURABILITY OF SUSTAINED VIROLOGIC RESPONSE IN COMBINATION THERAPY WITH INTERFERON/PEGINTERFERON AND RIBAVIRIN FOR CHRONIC HEPATITIS C
    Il Lee, Jung
    Lee, Jin-Woo
    Kim, Young Soo
    Shin, Yong Woon
    Lee, Don Hoeng
    Kim, Hyung Gil
    Jeong, Seok
    Park, Hyung Joo
    Park, Hyun Shin
    Hong, Soon-Sun
    HEPATOLOGY, 2008, 48 (04) : 906A - 907A
12345